Fraxiparine

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation. It is suitable for subcutaneous or intravenous administration, including during haemodialysis.

Fraxiparine is primarily used to prevent and treat blood clots. It is often administered to patients undergoing haemodialysis to maintain the patency of the dialysis circuit. This medication is also used for subcutaneous injection to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in certain high-risk individuals. What is Fraxiparine used for? It is commonly prescribed for anticoagulation therapy to reduce the risk of blood clots forming in the body.

Common effects of Fraxiparine may include bruising, bleeding, and pain at the injection site. Some users may experience swelling or redness where the medication was administered. These effects are generally mild and temporary. If you experience severe or persistent side effects, consult your healthcare provider.

Fraxiparine should be handled with care to avoid accidental injury. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication should be stored as directed, typically at room temperature, and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Fraxiparine may interact with other medications that affect blood clotting, such as warfarin or aspirin. It is important to discuss all current medications with your healthcare provider before starting Fraxiparine. Additionally, certain medical conditions, such as liver or kidney disease, may affect the safety and effectiveness of this medication. Always consult your healthcare provider for personalized advice.